Penile Intraepithelial Neoplasia and Other Premalignant Lesions of the Penis

Urologic Clinics of North America

Volumn 37, Issue 3, 2010, Pages 335-342

  Crispen, Paul L ^a   Mydlo, Jack H ^b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b TEMPLE UNIVERSITY HOSPITAL   (United States)

Author keywords

Human papilloma virus; Lichen sclerosis; Penile cancer; Penile intraepithelial neoplasia

Indexed keywords

CORTICOSTEROID; FLUOROURACIL; IMIQUIMOD; PLACEBO; STEROID; WART VIRUS VACCINE;

BASAL CELL CARCINOMA; CHEMOSURGERY; CLINICAL FEATURE; CONDYLOMA ACUMINATUM; CRYOSURGERY; DIFFERENTIAL DIAGNOSIS; DNA VIRUS INFECTION; DRUG EFFICACY; ELECTROSURGERY; HUMAN; LICHEN SCLEROSUS ET ATROPHICUS; MALIGNANT TRANSFORMATION; MELANOMA; PENILE BIOPSY; PENILE CUTANEOUS HORN; PENILE INTRAEPITHELIAL NEOPLASIA; PENIS CANCER; PENIS DISEASE; PRECANCER; PRIORITY JOURNAL; PSEUDOEPITHELIOMATOUS KERATOTIC AND MICACEOUS BALANITIS; REVIEW; SEXUALLY TRANSMITTED DISEASE; VIRUS CARCINOGENESIS; VIRUS TRANSMISSION; WART VIRUS;

CARCINOMA IN SITU; HUMANS; LICHEN SCLEROSUS ET ATROPHICUS; MALE; PAPILLOMAVIRUS INFECTIONS; PENILE NEOPLASMS; PRECANCEROUS CONDITIONS;

EID: 77955244467     PISSN: 00940143     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ucl.2010.04.003     Document Type: Review

References (60)

1. American Cancer Society. Facts and figures 2009. Available at: Accessed January 30, 2010. http://www.cancer.org/downloads/STT/500809web.pdf.
2. Dillner J., von Krogh G., Horenblas S., et al. Etiology of squamous cell carcinoma of the penis. Scand J Urol Nephrol Suppl 2000, (205):189-193.
3. von Krogh G., Horenblas S. The management and prevention of premalignant penile lesions. Scand J Urol Nephrol Suppl 2000, (205):220-229.
4. Tietjen D.N., Malek R.S. Laser therapy of squamous cell dysplasia and carcinoma of the penis. Urology 1998, 52(4):559-565.
5. Horenblas S., von Krogh G., Cubilla A.L., et al. Squamous cell carcinoma of the penis: premalignant lesions. Scand J Urol Nephrol Suppl 2000, (205):187-188.
6. Dillner J., Meijer C.J., von Krogh G., et al. Epidemiology of human papillomavirus infection. Scand J Urol Nephrol Suppl 2000, (205):194-200.
7. Grussendorf-Conen E.I., de Villiers E.M., Gissmann L. Human papillomavirus genomes in penile smears of healthy men. Lancet 1986, 2(8515):1092.
8. Gross G., Pfister H. Role of human papillomavirus in penile cancer, penile intraepithelial squamous cell neoplasias and in genital warts. Med Microbiol Immunol 2004, 193(1):35-44.
9. von Krogh G., Horenblas S. Diagnosis and clinical presentation of premalignant lesions of the penis. Scand J Urol Nephrol Suppl 2000, (205):201-214.
10. Grossman H.B. Premalignant and early carcinomas of the penis and scrotum. Urol Clin North Am 1992, 19(2):221-226.
11. Bleeker M.C., Heideman D.A., Snijders P.J., et al. Penile cancer: epidemiology, pathogenesis and prevention. World J Urol 2009, 27(2):141-150.
12. Obalek S., Jablonska S., Beaudenon S., et al. Bowenoid papulosis of the male and female genitalia: risk of cervical neoplasia. J Am Acad Dermatol 1986, 14(3):433-444.
13. Lont A.P., Kroon B.K., Horenblas S., et al. Presence of high-risk human papillomavirus DNA in penile carcinoma predicts favorable outcome in survival. Int J Cancer 2006, 119(5):1078-1081.
14. Cubilla A.L., Reuter V.E., Gregoire L., et al. Basaloid squamous cell carcinoma: a distinctive human papilloma virus-related penile neoplasm: a report of 20 cases. Am J Surg Pathol 1998, 22(6):755-761.
15. Porter W.M., Francis N., Hawkins D., et al. Penile intraepithelial neoplasia: clinical spectrum and treatment of 35 cases. Br J Dermatol 2002, 147(6):1159-1165.
16. Malek R.S. Human papillomavirus and carcinoma of the penis: modern concepts in pathogenesis and their impact on management of penile lesions 1999, vol. XIX. Update Series, AUA, Houston (TX), p. 1-7, Lesson 1.
17. Malek R.S., Goellner J.R., Smith T.F., et al. Human papillomavirus infection and intraepithelial, in situ, and invasive carcinoma of penis. Urology 1993, 42(2):159-170.
18. Aynaud O., Ionesco M., Barrasso R. Penile intraepithelial neoplasia. Specific clinical features correlate with histologic and virologic findings. Cancer 1994, 74(6):1762-1767.
19. Cubilla A.L., Velazquez E.F., Young R.H. Epithelial lesions associated with invasive penile squamous cell carcinoma: a pathologic study of 288 cases. Int J Surg Pathol 2004, 12(4):351-364.
20. Madsen B.S., van den Brule A.J., Jensen H.L., et al. Risk factors for squamous cell carcinoma of the penis-population-based case-control study in Denmark. Cancer Epidemiol Biomarkers Prev 2008, 17(10):2683-2691.
21. Wieland U., Jurk S., Weissenborn S., et al. Erythroplasia of Queyrat: coinfection with cutaneous carcinogenic human papillomavirus type 8 and genital papillomaviruses in a carcinoma in situ. J Invest Dermatol 2000, 115(3):396-401.
22. Barrasso R., De Brux J., Croissant O., et al. High prevalence of papillomavirus-associated penile intraepithelial neoplasia in sexual partners of women with cervical intraepithelial neoplasia. N Engl J Med 1987, 317(15):916-923.
23. Cubilla A.L., Meijer C.J., Young R.H. Morphological features of epithelial abnormalities and precancerous lesions of the penis. Scand J Urol Nephrol Suppl 2000, (205):215-219.
24. Gregoire L., Cubilla A.L., Reuter V.E., et al. Preferential association of human papillomavirus with high-grade histologic variants of penile-invasive squamous cell carcinoma. J Natl Cancer Inst 1995, 87(22):1705-1709.
25. Singh S., Bunker C. Male genital dermatoses in old age. Age Ageing 2008, 37(5):500-504.
26. Micali G., Nasca M.R., De Pasquale R. Erythroplasia of Queyrat treated with imiquimod 5% cream. J Am Acad Dermatol 2006, 55(5):901-903.
27. Taliaferro S.J., Cohen G.F. Bowen's disease of the penis treated with topical imiquimod 5% cream. J Drugs Dermatol 2008, 7(5):483-485.
28. Simmons P.D., Langlet F., Thin R.N. Cryotherapy versus electrocautery in the treatment of genital warts. Br J Vener Dis 1981, 57(4):273-274.
29. Veien S.K., Veien N.K., Hattel T., et al. Ugeskr Laeger 1996, 158(50):7213-7215. [in Danish].
30. Gerber G.S. Carcinoma in situ of the penis. J Urol 1994, 151(4):829-833.
31. Malloy T.R., Wein A.J., Carpiniello V.L. Carcinoma of penis treated with neodymium YAG laser. Urology 1988, 31(1):26-29.
32. Schlenker B., Gratzke C., Seitz M., et al. Fluorescence-guided laser therapy for penile carcinoma and precancerous lesions: long-term follow-up. Urol Oncol 2009, [Epub ahead of print].
33. Bissada N.K. Conservative extirpative treatment of cancer of the penis. Urol Clin North Am 1992, 19(2):283-290.
34. Mohs F.E., Snow S.N., Larson P.O. Mohs micrographic surgery for penile tumors. Urol Clin North Am 1992, 19(2):291-304.
35. Hadway P., Corbishley C.M., Watkin N.A. Total glans resurfacing for premalignant lesions of the penis: initial outcome data. BJU Int 2006, 98(3):532-536.
36. Kayes O., Ahmed H.U., Arya M., et al. Molecular and genetic pathways in penile cancer. Lancet Oncol 2007, 8(5):420-429.
37. Cubilla A.L., Velazquez E.F., Young R.H. Pseudohyperplastic squamous cell carcinoma of the penis associated with lichen sclerosus. An extremely well-differentiated, nonverruciform neoplasm that preferentially affects the foreskin and is frequently misdiagnosed: a report of 10 cases of a distinctive clinicopathologic entity. Am J Surg Pathol 2004, 28(7):895-900.
38. Soufir N., Queille S., Liboutet M., et al. Inactivation of the CDKN2A and the p53 tumour suppressor genes in external genital carcinomas and their precursors. Br J Dermatol 2007, 156(3):448-453.
39. Das S., Tunuguntla H.S. Balanitis xerotica obliterans-a review. World J Urol 2000, 18(6):382-387.
40. Pugliese J.M., Morey A.F., Peterson A.C. Lichen sclerosus: review of the literature and current recommendations for management. J Urol 2007, 178(6):2268-2276.
41. Garat J.M., Chechile G., Algaba F., et al. Balanitis xerotica obliterans in children. J Urol 1986, 136(2):436-437.
42. Jebakumar S.P., Woolley P.D. Balanitis xerotica obliterans. Int J STD AIDS 1995, 6(2):81-83.
43. Scurry J. Does lichen sclerosus play a central role in the pathogenesis of human papillomavirus negative vulvar squamous cell carcinoma? The itch-scratch-lichen sclerosus hypothesis. Int J Gynecol Cancer 1999, 9(2):89-97.
44. Nasca M.R., Innocenzi D., Micali G. Penile cancer among patients with genital lichen sclerosus. J Am Acad Dermatol 1999, 41(6):911-914.
45. Depasquale I., Park A.J., Bracka A. The treatment of balanitis xerotica obliterans. BJU Int 2000, 86(4):459-465.
46. Wallace H.J. Lichen sclerosus et atrophicus. Trans St Johns Hosp Dermatol Soc 1971, 57(1):9-30.
47. Barbagli G., Palminteri E., Mirri F., et al. Penile carcinoma in patients with genital lichen sclerosus: a multicenter survey. J Urol 2006, 175(4):1359-1363.
48. Pietrzak P., Hadway P., Corbishley C.M., et al. Is the association between balanitis xerotica obliterans and penile carcinoma underestimated?. BJU Int 2006, 98(1):74-76.
49. Powell J., Robson A., Cranston D., et al. High incidence of lichen sclerosus in patients with squamous cell carcinoma of the penis. Br J Dermatol 2001, 145(1):85-89.
50. Weber P., Rabinovitz H., Garland L. Verrucous carcinoma in penile lichen sclerosus et atrophicus. J Dermatol Surg Oncol 1987, 13(5):529-532.
51. Jamieson N.V., Bullock K.N., Barker T.H. Adenosquamous carcinoma of the penis associated with balanitis xerotica obliterans. Br J Urol 1986, 58(6):730-731.
52. Ganem J.P., Steele B.W., Creager A.J., et al. Pseudo-epitheliomatous keratotic and micaceous balanitis. J Urol 1999, 161(1):217-218.
53. Nayyar R., Singh P., Seth A. Penile cutaneous horn over long standing radiation dermatitis. J Postgrad Med 2009, 55(4):287.
54. Mastrolorenzo A., Tiradritti L., Locunto U., et al. Incidental finding: a penile cutaneous horn. Acta Derm Venereol 2005, 85(3):283-284.
55. Raghavaiah N.V., Soloway M.S., Murphy W.M. Malignant penile horn. J Urol 1977, 118(6):1068-1069.
56. Bleeker M.C., Hogewoning C.J., Voorhorst F.J., et al. Condom use promotes regression of human papillomavirus-associated penile lesions in male sexual partners of women with cervical intraepithelial neoplasia. Int J Cancer 2003, 107(5):804-810.
57. Hogewoning C.J., Bleeker M.C., van den Brule A.J., et al. Condom use promotes regression of cervical intraepithelial neoplasia and clearance of human papillomavirus: a randomized clinical trial. Int J Cancer 2003, 107(5):811-816.
58. Harper D.M., Franco E.L., Wheeler C.M., et al. Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial. Lancet 2006, 367(9518):1247-1255.
59. Villa L.L., Costa R.L., Petta C.A., et al. Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol 2005, 6(5):271-278.
60. Hsueh P.R. Human papillomavirus, genital warts, and vaccines. J Microbiol Immunol Infect 2009, 42(2):101-106.